TARLATAMAB TRAS LA APROBACIÓN COMPLETA EN ESTADOS UNIDOS PARA EL TRATAMIENTO SMALL CELL LUNG CANCER EXTENSIVE-STAGE ... AHORA LE TOCA EL TURNO DE CONSEGUIR LA FULL APPROVAL EN EUROPA ... LA EMA PODRÍA DAR SU BENDICIÓN EN LA REUNIÓN DE MARZO .
21 noviembre 2022
Legend Biotech Gets FDA Clearance for Small Cell Lung Cancer Trial .
Nov. 21, 2022 at 9:17 a.m. ET
By Sabela Ojea
The company, engaged in the discovery and development of novel cell therapies for oncology and other indications, said the Phase 1 trial for its LB2102 drug is designed to evaluate the safety and preliminary efficacy of the treatment while seeking to determine the recommended dose for a Phase 2 trial . ...






.jpeg)
